secwatch.observer — SEC 8-K summary
======================================

Issuer:     bluebird bio, Inc. (—)
CIK:        0001293971
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001193125-24-166322
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

bluebird bio appoints Michael Cloonan to Board as Class I director effective June 20, 2024
--------------------------------------------------------------------------------

- Michael Cloonan appointed as Class I director, effective June 20, 2024.
- Annual retainer of $45,000; initial grant of 74,775 stock options and 37,350 RSUs.
- Stock options and RSUs vest ratably over three years; standard indemnification agreement.
- No family relationships with other directors/officers, no reportable transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293971/000119312524166322/0001193125-24-166322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293971/000119312524166322/d826411d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-166322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer